Taoka Chemical Company, Limited revised consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company now expects sales revenue of JPY 28,000 million, operating income of JPY 700 million, net income attributable to owners of the parent of JPY 400 million and net income per share of JPY 27.92 against sales revenue of JPY 32,000 million, operating income of JPY 700 million, net income attributable to owners of the parent of JPY 400 million and net income per share of JPY 27.92 as previously forecasted.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
780 JPY | 0.00% | +4.00% | +8.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.18% | 71M | |
-0.19% | 74.89B | |
+0.09% | 46.52B | |
-4.19% | 30.82B | |
+9.85% | 18.19B | |
-10.05% | 11.54B | |
+6.39% | 11.24B | |
-8.09% | 9.73B | |
+2.79% | 9.4B | |
+6.35% | 9.37B |
- Stock Market
- Equities
- 4113 Stock
- News Taoka Chemical Company, Limited
- Taoka Chemical Company, Limited Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024